Table 1.
Sample Demographics
| Overall Sample (n = 64) | Non-risk Sample (n = 38) | Risk Sample (n = 26) | t-test/χ2 | |
|---|---|---|---|---|
| Age, M (SD) | 17.79 (1.21) | 17.62 (1.13) | 18.03 (1.31) | −1.34 (p = .186) |
| Gender, n (%) | .659 (p = .417) | |||
| Female | 33 (51.6) | 18 (47.4) | 15 (57.7) | |
| Male | 31 (48.4) | 20 (52.6) | 11 (42.3) | |
| Race/Ethnicity, n (%) | 8.52 (p = .074) | |||
| Non-Hispanic White | 32 (50.0) | 17 (44.7) | 15 (57.7) | |
| Hispanic | 6 (9.4) | 3 (7.9) | 3 (11.5) | |
| Black or African American | 23 (35.9) | 18 (47.4) | 5 (19.2) | |
| Asian | 1 (1.6) | 0 | 1 (3.9) | |
| Other | 2 (3.1) | 0 | 2 (7.7) | |
| Education, n (%) | 6.10 (p = .014) | |||
| High School | 41 (64.1) | 29 (76.3) | 12 (46.2) | |
| College | 23 (35.9) | 9 (23.7) | 14 (53.8) | |
| Living Situation, n (%) | 5.53 (p = .019) | |||
| At home | 51 (79.7) | 34 (89.5) | 17 (65.4) | |
| Away from home | 13 (20.3) | 4 (10.5) | 9 (34.6) | |
| HbA1c, M (SD) | 8.89 (2.41) | 8.83 (2.56) | 8.97 (2.20) | −.229 (p = .820) |
| Frequency of Blood Glucose Checks, M (SD) | 3.54 (2.35) | 3.71 (2.26) | 3.30 (2.51) | .616 (p = .541) |
| Disease Duration, years M (SD) | 8.18 (4.32) | 8.01 (4.72) | 8.42 (3.76) | −.360 (p = .720) |
| Regimen, n (%) | 1.08 (p = .583) | |||
| Pump | 22 (34.4) | 12 (31.6) | 10 (38.5) | |
| Basal/Bolus | 20 (31.3) | 11 (28.9) | 9 (34.6) | |
| Fixed Injections | 22 (34.4) | 15 (39.5) | 7 (26.9) |
Note. Risk sample is comprised of participants endorsing substance use within the past 30 days of their clinic visit.